Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Flevia Anthony
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
Observed institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
ORCID:
0000-0003-1664-0259
Observed ORCID:
0000-0003-1664-0259
OpenAlex ID:
A5114235468
The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells
2025
·
Anjali Singh
, Abhiram Natu
, et al.
·
Clinical Epigenetics
·
4
PDF
Raman spectroscopy for detecting gastric and liver cancer cells that entered a tolerant persistence state to survive cisplatin chemotherapy
2025
·
Anjali Singh
, Ishika Gupta
, et al.
·
Biochemical and Biophysical Research Communications
·
2
Metabolic-epigenetic reprogramming with low-dose metformin and valproic acid sensitizes drug-tolerant persister cells to cisplatin in gastric and liver cancer
2026
·
Anjali Singh
, Abhiram Natu
, et al.
·
Cancer & Metabolism
Identical Dual H3 Phosphoacetylation in G0/G1 and G2/M Phase of Cell Cycle: Any Functional Relevance?
2024
·
Flevia Anthony
, Sanjay Gupta
·
Indian Journal of Medical and Paediatric Oncology
Show more works
View as search
Works count:
4
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type